Illinois General Assembly - Full Text of HR0196
Illinois General Assembly

Previous General Assemblies

Full Text of HR0196  101st General Assembly




HR0196LRB101 11554 MST 57474 r


2    WHEREAS, Vaccines have reduced the burden of widespread and
3often fatal diseases, enabling individuals to lead longer and
4healthier lives, while reducing health care costs; and
5    WHEREAS, Healthy People 2020 maintains goals of increasing
6immunization rates and reducing preventable infectious
7diseases in the United States; and
8    WHEREAS, The Centers for Disease Control and Prevention
9(CDC), the American Academy of Pediatrics, and the Society for
10Adolescent Health and Medicine recommend that all adolescents
11aged 11 to 12 years get annual check-ups; and
12    WHEREAS, Safe and effective vaccines exist for the preteen
13adolescent population, such as those for meningococcal
14disease, human papillomavirus, influenza, tetanus, diphtheria,
15pertussis, measles, mumps, and rubella; and
16    WHEREAS, Babies, teens, and young adults have higher rates
17of meningococcal disease than people of other ages; and
18    WHEREAS, In 2016, the incidence of meningococcal disease in
19the United States was 0.12 per 100,000 people, and 10 to 15 out
20of every 100 people infected with meningococcal disease will



HR0196- 2 -LRB101 11554 MST 57474 r

1die; and
2    WHEREAS, The Advisory Committee on Immunization Practices
3(ACIP) recommends that all adolescents aged 11 to 12 years be
4vaccinated with a meningococcal conjugate vaccine; and
5    WHEREAS, The CDC estimates that influenza has resulted in
6between 9.3 million to 49 million illnesses, 140,000 to 960,000
7hospitalizations, and 12,000 to 79,000 deaths annually in the
8United States since 2010; and
9    WHEREAS, The ACIP recommends routine annual influenza
10vaccination for all individuals above the age of six months who
11do not have contraindications; and
12    WHEREAS, Of the 18,975 cases of Pertussis that were
13reported in the United States in 2018, 1,595 were among
14adolescents aged 7 to 10 years and 4,214 were among adolescents
15aged 11 to 19 years; and
16    WHEREAS, The ACIP recommends routine vaccination for
17tetanus, diphtheria, and pertussis; and
18    WHEREAS, The ACIP recommends that adolescents 11 and 12
19years of age receive a single dose of the tetanus, diphtheria,
20and pertussis vaccination, and adolescents and young adults 13



HR0196- 3 -LRB101 11554 MST 57474 r

1and 18 years of age, who have not received the tetanus,
2diphtheria, and pertussis vaccination, receive one dose; and
3    WHEREAS, The CDC estimates that there was a total of 3,218
4cases of acute hepatitis B in the United States in 2016 and an
5incidence rate of 1.0 cases per 100,000 people in the United
6States in the same year; and
7    WHEREAS, The ACIP recommends catch-up hepatitis B
8vaccination for adolescents aged 11-15 years using an
9alternative 2-dose schedule with at least 4 months between
10doses; and
11    WHEREAS, In 2018, the United States experienced 17 measles
12outbreaks, and the majority of people who got measles were
13unvaccinated; in 2016, the CDC reported a total of 6,366 cases
14of mumps in the United States; and
15    WHEREAS, The ACIP recommends vaccination against measles,
16mumps, and rubella for teens and adults at post-high school
17educational institutions, international travelers, healthcare
18professionals, women of childbearing age who are not pregnant,
19people who care for or are around immunocompromised people, and
20people living with HIV who are not showing signs of severe
21immunosuppression; and



HR0196- 4 -LRB101 11554 MST 57474 r

1    WHEREAS, The CDC estimates that there are more than 3.5
2million cases of varicella infection and 9,000 related
3hospitalizations annually in the United States; and
4    WHEREAS, The ACIP recommends that children and adolescents
5between the ages of 7 and 12 years, who have no evidence of
6immunity, receive a 2-dose series of the varicella vaccine 4
7weeks to 3 months apart, and the ACIP recommends that
8adolescents over the age of 13 years receive 2 doses of the
9varicella vaccine 4 to 8 weeks apart; and
10    WHEREAS, The CDC estimates that there are 33,700 cases of
11human papillomavirus-associated cancers diagnosed annually in
12the United States, with 24,400 cases among women and 18,3000
13cases among men; and
14    WHEREAS, The human papillomavirus vaccine offers
15long-lasting protection against human papillomavirus infection
16and therefore the disease caused by the infection; and
17    WHEREAS, The ACIP recommends routine vaccination against
18the human papillomavirus vaccine for all adolescents between
19the ages of 11 and 12 years and as early as 9 years; therefore,
20be it



HR0196- 5 -LRB101 11554 MST 57474 r

2the week of August 5, 2019 is declared "Adolescent Immunization
3Week" in Illinois to increase public awareness of the
4importance of preteens and adolescents receiving vaccines
5against meningococcal disease, human papillomavirus,
6influenza, tetanus, diphtheria, pertussis, measles, mumps, and
7rubella, and to promote outreach and education efforts
8concerning vaccination; and be it further
9    RESOLVED, That the Illinois Department of Public Health is
10urged to promote Adolescent Immunization Week by requesting
11health care practitioners discuss infectious diseases with
12preteen patients and their parents or guardians, and by
13adopting appropriate programs and initiatives to raise public
14awareness of the importance of preteen vaccination against
15meningococcal disease, human papillomavirus, influenza,
16tetanus, diphtheria, pertussis, measles, mumps, and rubella;
17and be it further
18    RESOLVED, That the Illinois Department of Public Health is
19urged to create and disseminate educational resources on
20meningococcal disease, human papillomavirus, influenza,
21tetanus, diphtheria, pertussis, measles, mumps, rubella, and
22available vaccinations, while coordinating with local health
23authorities to host annual health and immunization focused
24fairs to educate the residents of Illinois on



HR0196- 6 -LRB101 11554 MST 57474 r

1vaccine-preventable diseases; and be it further
2    RESOLVED, That the Illinois Department of Public Health is
3urged to identify and coordinate with other agencies to ensure
4that informed and proper vaccine quality measures pertinent to
5adolescent vaccines are included in measurement frameworks and
6reporting programs; and be it further
7    RESOLVED, That a suitable copy of this resolution be
8delivered to the Illinois Department of Public Health.